A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America
- PMID: 38687439
- DOI: 10.1007/s10689-024-00382-3
A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America
Abstract
MUTYH-Associated Polyposis (MAP) is caused by biallelic pathogenic germline variants in the MUTYH gene. However, individuals harboring monoallelic MUTYH pathogenic variants in the presence of a positive family history have been reported to have a twofold increased risk of colorectal cancer (CRC) and extra colonic cancers. Our aim was to characterize the spectrum of monoallelic and biallelic germline MUTYH pathogenic variants in Latin American patients and to describe their clinical and genetic characteristics. Patients were identified from eight high-risk genetic cancer centers of five Latin American countries. Statistical analysis was performed using the two-sided P test using the Vassarstats statistical tools. Statistical significance was set at a p value ≤ 0.05. Of the 105 unrelated patients with cancer or colorectal polyposis, 84.8% and 15.2% carried pathogenic monoallelic and biallelic MUTYH variants, respectively. The most common pathogenic variants were p.Gly396Asp and p.Tyr179Cys (55% and 23%, respectively). The mean age at first diagnosis was 48.29 years (range 31-71) and 49.90 years (range 27-87) in biallelic and monoallelic MUTYH patients, respectively. CRC was the only cancer diagnosed in patients with biallelic MUTYH pathogenic variants (75%), while breast cancer (46.1%) was more common than CRC (24.7%) in individuals with monoallelic MUTYH pathogenic variants. We reported a high frequency of European founder variants in our diverse population. Some phenotypic differences from current studies were identified, such as a higher breast cancer burden in monoallelic carriers and a complete absence of extra-colon tumors in biallelic patients.
Keywords: MUTYH; Genotype; Latin America; Phenotype.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.Fam Cancer. 2021 Apr;20(2):111-116. doi: 10.1007/s10689-020-00198-x. Epub 2020 Aug 3. Fam Cancer. 2021. PMID: 32743790 Free PMC article.
-
MUTYH hotspot mutations in unselected colonoscopy patients.Colorectal Dis. 2012 May;14(5):e238-44. doi: 10.1111/j.1463-1318.2012.02920.x. Colorectal Dis. 2012. PMID: 22469480
-
MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.Clin Genet. 2010 Oct;78(4):353-63. doi: 10.1111/j.1399-0004.2010.01478.x. Clin Genet. 2010. PMID: 20618354
-
MUTYH-associated tumor syndrome: The other face of MAP.Oncogene. 2022 Apr;41(18):2531-2539. doi: 10.1038/s41388-022-02304-y. Epub 2022 Apr 14. Oncogene. 2022. PMID: 35422474 Review.
-
MutYH-associated polyposis.Ter Arkh. 2019 Mar 18;91(2):97-100. doi: 10.26442/00403660.2019.02.000124. Ter Arkh. 2019. PMID: 31094179 Review.
References
-
- Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149(4):778–789 - DOI
-
- Medina Pabón MA, Babiker HM (2022) A review of hereditary colorectal cancers. StatPearls Publishing, StatPearls
-
- Hampel H (2018) Population screening for hereditary colorectal cancer. Surg Oncol Clin N Am 2:319–325 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials